Category

Examples

Immunocompromising conditions

Cancer

Non-haematological cancer including those diagnosed within the past 5 years or on chemotherapy, radiotherapy, immunotherapy or targeted anti-cancer therapy (active treatment or recently completed) or with advanced disease regardless of treatment. Survivors of childhood cancer.

Chronic inflammatory conditions requiring medical treatment with disease modifying anti-rheumatic drugs (DMARDs) or immune-suppressive or immunomodulatory therapies.

Systemic lupus erythematosus, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and similar who are being treated.

Chronic lung disease

Chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease and severe asthma (defined as requiring frequent hospital visits or the use of multiple medications).

Chronic liver disease

Cirrhosis, autoimmune hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease.

Severe chronic kidney disease (stage 4 or 5)

Chronic neurological disease

Stroke, neurodegenerative disease (e.g dementia, motor neurone disease, Parkinson’s disease), myasthenia gravis, multiple sclerosis, cerebral palsy, myopathies, paralytic syndromes, epilepsy.

Diabetes mellitus requiring medication

Chronic cardiac disease

Ischaemic heart disease, valvular heart disease, congestive cardiac failure, cardiomyopathies, poorly controlled hypertension, pulmonary hypertension, complex congenital heart disease.

People with disability with significant or complex health needs or multiple comorbidities which increase risk of poor outcome from COVID-19

Particularly those with trisomy 21 (Down Syndrome) or complex multi-system disorders.

Severe obesity with BMI ≥ 40 kg/m2

Severe underweight with BMI < 16.5 kg/m2